{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Antitumor activity", "Cancer cell lines", "SAR", "Structural diversity", "Synthetic strategies", "\u03b2-carbolines"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "33684825", "DateCompleted": {"Year": "2021", "Month": "04", "Day": "22"}, "DateRevised": {"Year": "2021", "Month": "04", "Day": "22"}, "Article": {"ArticleDate": [{"Year": "2021", "Month": "02", "Day": "24"}], "Language": ["eng"], "ELocationID": ["10.1016/j.ejmech.2021.113321", "S0223-5234(21)00170-7"], "Journal": {"ISSN": "1768-3254", "JournalIssue": {"Volume": "216", "PubDate": {"Year": "2021", "Month": "Apr", "Day": "15"}}, "Title": "European journal of medicinal chemistry", "ISOAbbreviation": "Eur J Med Chem"}, "ArticleTitle": "\u03b2-Carbolines as potential anticancer agents.", "Pagination": {"StartPage": "113321", "MedlinePgn": "113321"}, "Abstract": {"AbstractText": ["\u03b2-Carbolines are indole alkaloids having a tricyclic pyrido[3,4-b]indole ring in their structure. Since the isolation of first \u03b2-carboline from Peganum harmala in 1841, the isolation and synthesis of various \u03b2-carboline derivatives surged in the following centuries. \u03b2-Carboline derivatives due to their widespread availability from natural sources, structural flexibility, quick reactivity and interaction with varied anticancer targets such as DNA (intercalation, groove binding, etc.), enzymes (GPX4, topoisomerases, kinases, etc.) and proteins (tubulin, ABCG2/BRCP1, etc.) have established themselves as promising lead compounds for the synthesis of various anticancer active agents. The current review covers the synthesis and isolation, anticancer activity, mechanism of action and SAR of various \u03b2-carboline containing molecules, its derivatives and congeners."], "CopyrightInformation": "Copyright \u00a9 2021 Elsevier Masson SAS. All rights reserved."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Medicinal Chemistry, National Institute of Pharmaceutical Education and Research (NIPER), S.A.S Nagar, Mohali, Punjab, India."}], "LastName": "Aaghaz", "ForeName": "Shams", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Medicinal Chemistry, National Institute of Pharmaceutical Education and Research (NIPER), S.A.S Nagar, Mohali, Punjab, India."}], "LastName": "Sharma", "ForeName": "Komal", "Initials": "K"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Medicinal Chemistry, National Institute of Pharmaceutical Education and Research (NIPER), S.A.S Nagar, Mohali, Punjab, India."}], "LastName": "Jain", "ForeName": "Rahul", "Initials": "R"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Pharmaceutical Education and Research (SPER), Jamia Hamdard, New Delhi, India. Electronic address: ahmedkamal915@gmail.com."}], "LastName": "Kamal", "ForeName": "Ahmed", "Initials": "A"}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "France", "MedlineTA": "Eur J Med Chem", "NlmUniqueID": "0420510", "ISSNLinking": "0223-5234"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Antineoplastic Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Carbolines"}, {"RegistryNumber": "0", "NameOfSubstance": "Intercalating Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Tubulin"}, {"RegistryNumber": "EC 2.7.11.1", "NameOfSubstance": "Proto-Oncogene Proteins B-raf"}, {"RegistryNumber": "EC 2.7.11.22", "NameOfSubstance": "Cyclin-Dependent Kinases"}, {"RegistryNumber": "EC 5.99.1.-", "NameOfSubstance": "DNA Topoisomerases"}], "MeshHeadingList": [{"QualifierName": ["chemistry", "therapeutic use"], "DescriptorName": "Antineoplastic Agents"}, {"QualifierName": ["chemistry", "therapeutic use"], "DescriptorName": "Carbolines"}, {"QualifierName": ["antagonists & inhibitors", "metabolism"], "DescriptorName": "Cyclin-Dependent Kinases"}, {"QualifierName": ["chemistry", "metabolism"], "DescriptorName": "DNA Topoisomerases"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["chemistry", "therapeutic use"], "DescriptorName": "Intercalating Agents"}, {"QualifierName": ["drug therapy", "pathology"], "DescriptorName": "Neoplasms"}, {"QualifierName": ["chemistry", "metabolism"], "DescriptorName": "Plants"}, {"QualifierName": ["antagonists & inhibitors", "metabolism"], "DescriptorName": "Proto-Oncogene Proteins B-raf"}, {"QualifierName": ["chemistry", "metabolism"], "DescriptorName": "Tubulin"}], "CoiStatement": "Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper."}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "2020", "Month": "8", "Day": "11"}, {"Year": "2021", "Month": "2", "Day": "14"}, {"Year": "2021", "Month": "2", "Day": "16"}, {"Year": "2021", "Month": "3", "Day": "9", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "4", "Day": "23", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "3", "Day": "8", "Hour": "20", "Minute": "16"}], "PublicationStatus": "ppublish", "ArticleIdList": ["33684825", "10.1016/j.ejmech.2021.113321", "S0223-5234(21)00170-7"]}}], "PubmedBookArticle": []}